DNA Script

About:

DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.

Website: https://www.dnascript.com

Twitter/X: DNAScript

Top Investors: Bpifrance, Alexandria Venture Investments, Fidelity, AGORANOV, Coatue

Description:

DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.

Total Funding Amount:

$480M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Le Kremlin-bicĂȘtre, Ile-de-France, France

Founded Date:

2014-01-01

Contact Email:

contact(AT)dnascript.com

Founders:

Sylvain Gariel, Thomas Ybert, Xavier Godron

Number of Employees:

251-500

Last Funding Date:

2022-08-27

IPO Status:

Private

© 2025 bioDAO.ai